Merestinib Recruiting Phase 2 Trials for Tumors, Solid / Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02920996Merestinib In Non-Small Cell Lung Cancer And Solid Tumors